Cancer News and Research

Latest Cancer News and Research

Mursla Bio's EvoLiver surpasses current standards in liver cancer surveillance, data presented at AASLD Liver Meeting 2024

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients through the power of dynamic biopsy technology, today announced results of its multi-center clinical study, MEV01, in collaboration with leading academic institutes including University College London, Imperial College London, University Hospital of Santa Maria and the Medical University of Graz.

From Mursla Bio 25 Nov 2024

The silent struggles of men’s mental health and suicide prevention

Globally, the month of November is associated with campaigns to raise awareness and encourage conversation around men's health, particularly on topics such as prostate cancer, testicular cancer, mental health and suicide prevention.

25 Nov 2024

Study points to a strategy for inhibiting hyper-progression of melanoma

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

25 Nov 2024

Mursla Bio announces promising results for EvoLiver test in liver cancer detection

25 Nov 2024

Study shows growing cancer treatment inequities between high and low-income countries

A recent analysis reveals striking disparities in the cost and availability of cancer drugs across different regions of the globe, with significant gaps between high- and low-income countries. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.

25 Nov 2024

Could medical imaging innovation be the catalyst for precision medicine?

Precision medicine leverages genetic and lifestyle data to customize treatments, enhancing healthcare efficiency and patient outcomes in disease management.

24 Nov 2024

Golgi apparatus plays crucial role in enhancing T-cell function against cancer

The Golgi apparatus modifies, sorts and packages proteins to be sent to their final destinations, whether that's within or outside of the cell.

23 Nov 2024

UChicago scientists develop a new approach to study snoRNAs

Dynamic, reversible modifications of DNA and RNA regulate how genes are expressed and transcribed, which can influence cellular processes, disease development, and overall organismal health.

23 Nov 2024

Barcelona launches world’s first joint program on evolutionary medical genomics

Three research institutions in Barcelona have teamed up to launch the world's first Joint Program on Evolutionary Medical Genomics.

22 Nov 2024

Many Americans unaware of alcohol's cancer risks, survey shows

Although the Centers for Disease Control and Prevention (CDC) says that you can "lower your risk for cancer by drinking less alcohol or not drinking at all," Annenberg Public Policy Center (APPC) data show that less than half of Americans know that regularly drinking alcohol increases the risk of later developing cancer.

22 Nov 2024

USC and Autobahn Labs team up to advance breakthrough drug research

USC has embarked on a collaboration with Autobahn Labs, an accelerator for early-stage drug discovery, to identify and advance cutting-edge scientific findings into new therapies - with a special focus on critical unmet medical needs.

22 Nov 2024

Study reveals how brainstem neurons control eye movements

Working with week-old zebrafish larva, researchers at Weill Cornell Medicine and colleagues decoded how the connections formed by a network of neurons in the brainstem guide the fishes' gaze.

22 Nov 2024

Penn engineers cook up a new way for safer, more effective mRNA therapies

Penn Engineers have cooked up a new way to improve mRNA delivery, developing an optimal "recipe" for ionizable lipids - key ingredients in lipid nanoparticles (LNPs), the molecules behind the COVID-19 vaccines and other innovative therapies.

22 Nov 2024

Researchers discover key protein interaction driving skin cancer growth

LMU researchers have discovered how the interplay between a key protein and an endolysosomal ion channel promotes tumor development in skin cancer.

22 Nov 2024

Environmental factors contribute to higher PFAS exposure in Southern California

Evidence is mounting on the health problems linked to per- and polyfluoroalkyl substances (PFAS), a group of manufactured chemicals used in consumer products that accumulate in the body and take a very long time to break down.

22 Nov 2024

AI-designed drug ISM5939 granted IND clearance for cancer clinical trials

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has received IND clearance from FDA for ISM5939, a potential best-in-class oral small molecule inhibitor targeting ENPP1 for the treatment of solid tumors.

22 Nov 2024

Study sheds light on how cells repair damaged DNA

New research from the Kind Group at the Hubrecht Institute sheds light on how cells repair damaged DNA. For the first time, the team has mapped the activity of repair proteins in individual human cells.

22 Nov 2024

Nanomedicine using gas bubbles offers hope for lung cancer treatment

The delivery of nanomedicines using gas bubbles has shown itself to be a unique way of transporting cytotoxins to the lungs of cancer patients.

22 Nov 2024

Shift to sustainable diets could cut global mortality by 27%

The Planetary Health Diet may prevent 15 million deaths annually, offering a sustainable solution to improve health and meet global sustainability objectives.

22 Nov 2024

Advanced diagnostic kit developed for detecting highly pathogenic H5N1 avian influenza virus

The Diagnostics Development Hub (DxD Hub), a national platform hosted by the Agency for Science, Technology and Research (A*STAR), Singapore, in collaboration with the National Institute for Environmental Studies (NIES), Japan, and the A*STAR Bioinformatics Institute (A*STAR BII), has successfully developed Steadfast, an advanced diagnostic kit for detecting the highly pathogenic H5N1 Avian Influenza Virus (AIV).

22 Nov 2024